These results are further supported by a recent meta-analysis of 28 studies involving over 13,000 individuals that also identified these alleles as important markers of disease severity, highlighting the critical role of HLA-DRB1 in COVID-19 progression [12]. This evidence concerns the gene HLA-DRB1 and COVID-19.